BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 207346)

  • 1. Studies of the cyanogen bromide fragments of the apoprotein of human serum low density lipoproteins.
    Deutsch DG; Heinrikson RL; Foreman J; Scanu AM
    Biochim Biophys Acta; 1978 May; 529(2):342-50. PubMed ID: 207346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cyanogen bromide peptides of the apoprotein of low density lipoprotein (ApoB): its molecular weight from a chemical view.
    Bradley WA; Rohde MF; Gotto AM; Jackson RL
    Biochem Biophys Res Commun; 1978 Apr; 81(3):928-35. PubMed ID: 208540
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on the composition of pig serum lipoproteins. Isolation and characterization of different apoproteins.
    Knipping GM; Kostner GM; Holasek A
    Biochim Biophys Acta; 1975 May; 393(1):88-99. PubMed ID: 166686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and characterization of the seven cyanogen bromide fragments of human serum transferrin.
    Sutton MR; Brew K
    Biochem J; 1974 Apr; 139(1):163-8. PubMed ID: 4463940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The primary structure of Lactobacillus casei thymidylate synthetase. I. The isolation of cyanogen bromide peptides 1 through 5 and the complete amino acid sequence of CNBr 1, 2, 3, and 5.
    Maley GF; Bellisario RL; Guarino DU; Maley F
    J Biol Chem; 1979 Feb; 254(4):1288-95. PubMed ID: 105003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary structure of the C-terminal cyanogen bromide fragments II, III and IV from bovine brain proteolipid-apoprotein.
    Stoffel W; Hillen H; Schroeder W; Deutzmann R
    Hoppe Seylers Z Physiol Chem; 1982 Aug; 363(8):855-64. PubMed ID: 7118077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the primary structure of the strongly hydrophobic brain myelin proteolipid apoprotein (lipophilin). Isolation and amino acid sequence determination of proteolytic fragments.
    Stoffel W; Schröder W; Hillen H; Deutzmann R
    Hoppe Seylers Z Physiol Chem; 1982 Sep; 363(9):1117-31. PubMed ID: 7141416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bovine peripheral nervous system myelin P2 protein: chemical and immunological characterization of the cyanogen bromide peptides.
    Weise MJ; Hsieh D; Hoffman PM; Powers JM; Brostoff SW
    J Neurochem; 1980 Aug; 35(2):393-9. PubMed ID: 6161221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sea-anemone collagen: isolation and characterization of the cyanogen-bromide peptides.
    Nowack H; Nordwig A
    Eur J Biochem; 1974 Jun; 45(2):333-42. PubMed ID: 4153051
    [No Abstract]   [Full Text] [Related]  

  • 10. Structural studies on a glycoprotein isolated from alveoli of patients with alveolar proteinosis.
    Bhattacharyya SN; Sahu S; Lynn WS
    Biochim Biophys Acta; 1976 Mar; 427(1):91-106. PubMed ID: 1260011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary structure of very low density apolipoprotein C-II of human plasma.
    Jackson RL; Baker HN; Gilliam EB; Gotto AM
    Proc Natl Acad Sci U S A; 1977 May; 74(5):1942-5. PubMed ID: 194244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The distribution and partial characterization of the serum apolipoproteins in the guinea pig.
    Chapman MJ; Mills GL; Ledford JH
    Biochem J; 1975 Aug; 149(2):423-36. PubMed ID: 170915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The primary structure of Escherichia coli K12 aspartokinase I-homoserine dehydrogenase I-Isolation and characterisation of the peptides produced by cyanogen bromide.
    Cossart-Gheerbrant P; Sibilli-Weill L; Briley PA; Chalvignac MA; Le Bras G; Cohen GN
    Biochim Biophys Acta; 1978 Aug; 535(2):206-15. PubMed ID: 354697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The catalytic chain of human complement subcomponent C1r. Purification and N-terminal amino acid sequences of the major cyanogen bromide-cleavage fragments.
    Arlaud GJ; Gagnon J; Porter RR
    Biochem J; 1982 Jan; 201(1):49-59. PubMed ID: 6282261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel method for converting apolipoprotein B, the major protein moiety of human plasma low density lipoproteins, into a water-soluble protein.
    Huang SS; Lee DM
    Biochim Biophys Acta; 1979 Apr; 577(2):424-41. PubMed ID: 222336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of the cystine-containing apolipoprotein of human plasma high density lipoproteins: characterization of cyanogen bromide and tryptic fragments.
    Jackson RL; Gotto AM
    Biochim Biophys Acta; 1972 Nov; 285(1):36-47. PubMed ID: 4347238
    [No Abstract]   [Full Text] [Related]  

  • 17. Cyanogen bromide cleaves Fc fragments of pooled human IgG at both methionine and tryptophan residues.
    Boulware DW; Goldsworthy PD; Nardella FA; Mannik M
    Mol Immunol; 1985 Dec; 22(12):1317-22. PubMed ID: 3831770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Primary structure of the cytoplasmic aspartate aminotransferases from the swine myocardium. Isolation, purification and characteristics of the peptides from cyanogen bromide cleavage].
    Nosikov VV; Polianovskiĭ OL; Braunshtein AE; Grishin EV; Ovchinnikov IuA
    Biokhimiia; 1975; 40(1):107-14. PubMed ID: 1138991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Properties of the plasma very low and low density lipoproteins in Tangier disease.
    Heinen RJ; Herbert PN; Fredrickson DS
    J Clin Invest; 1978 Jan; 61(1):120-32. PubMed ID: 201668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The surface-exposed, trypsin-accessible segments of apolipoprotein B in the low-density lipoprotein of human serum. Fractionation and characterisation of the liberated peptides.
    Chapman MJ; Millet A; Lagrange D; Goldstein S; Blouquit Y; Taylaur CE; Mills GL
    Eur J Biochem; 1982 Jul; 125(3):479-89. PubMed ID: 7117246
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.